Halozyme Therapeutics
HALO
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Hutchmed (China)
HCM
US Stock MarketDetailed Quotes
PCRFF PANASONIC HOLDINGS CORP
- 10.025
- 0.0000.00%
15min DelayTrading Dec 18 16:00 ET
23.40BMarket Cap10.52P/E (TTM)
0.000High0.000Low36Volume9.250Open10.025Pre Close0.00Turnover0.00%Turnover Ratio8.16P/E (Static)2.33BShares10.51052wk High0.81P/B23.40BFloat Cap6.74252wk Low0.26Dividend TTM2.33BShs Float13.459Historical High2.60%Div YieldTTM0.00%Amplitude6.583Historical Low0.000Avg Price1Lot Size
PANASONIC HOLDINGS CORP Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | -63.08%76.24B | 65.90%465.44B | -52.52%51.27B | 105.37%116.21B | 44.22%91.47B | 292.85%206.5B | 5.70%280.56B | 76.30%107.98B | 31.37%56.59B | -20.59%63.42B |
| Deferred tax | ---- | -212.14%-40.2B | 111.04%5.19B | -12.40%28.24B | -18.62%24.13B | -566.02%-97.77B | -62.24%35.85B | -337.84%-47.02B | 5.57%32.24B | 70.79%29.65B |
| Other non cash items | ---- | -1,456.92%-211.51B | -134.53%-7.19B | -86.26%-79.99B | -158.23%-62.47B | -288.94%-61.86B | 89.32%-13.59B | 169.64%20.81B | -310.75%-42.95B | 80.06%-24.19B |
| Change In working capital | -58.65%49.26B | 518.31%297.11B | 137.46%101.1B | 37,953.16%59.81B | 127.78%17.09B | 329.42%119.12B | 61.00%-71.03B | 150.98%42.57B | 99.75%-158M | 16.32%-61.52B |
| -Change in receivables | 13.33%80.07B | 95.97%50.55B | -82.49%-54.14B | -1.47%36.11B | 83.94%-2.06B | 123.14%70.65B | 147.91%25.8B | -31.47%-29.67B | 171.43%36.65B | -269.79%-12.84B |
| -Change in inventory | 14.57%-37.86B | 226.69%152.82B | -2.37%125.68B | 243.75%32.43B | 139.83%39.03B | 65.59%-44.32B | 46.61%-120.62B | 908.17%128.73B | 51.79%-22.56B | -28.14%-97.99B |
| -Change in other current assets | -121.81%-9.49B | 1,029.83%136.05B | 200.67%60.65B | 466.63%22.48B | 154.10%9.42B | 862.51%43.5B | -65.68%12.04B | -39.78%20.17B | -158.60%-6.13B | 143.11%3.71B |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 0.61%228B | 66.47%866.9B | 29.73%268.57B | 97.79%206.58B | 90.32%165.14B | 84.97%226.62B | 106.13%520.74B | 39.22%207.02B | 67.49%104.44B | 198.03%86.77B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Net PPE purchase and sale | -71.47%-192.19B | -93.84%-504.1B | -83.22%-170.66B | -73.73%-104.24B | -123.73%-117.13B | -105.42%-112.09B | -51.91%-260.06B | -557.59%-93.14B | -12.31%-60B | -11.61%-52.35B |
| Net intangibles purchase and sale | ---- | -23.84%-99.73B | -39.62%-31.19B | -31.46%-25.45B | -9.99%-24.5B | -12.27%-18.59B | -26.21%-80.53B | -25.41%-22.34B | -20.66%-19.36B | -49.90%-22.28B |
| Net business purchase and sale | -201.28%-6.01B | 663.55%27.54B | 157.21%6.54B | -1,043.18%-22.33B | 506.95%37.39B | 398.39%5.93B | 99.16%-4.89B | -197.11%-11.43B | -12.30%2.37B | 101.04%6.16B |
| Net other investing changes | -1,128.08%-16.53B | -276.82%-2.55B | -143.26%-3.23B | 59.17%1.95B | -96.98%81M | -18.38%-1.35B | -93.06%1.44B | -352.76%-1.33B | -85.86%1.22B | -74.48%2.68B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -70.29%-214.73B | -68.25%-578.84B | -54.82%-198.54B | -98.06%-150.06B | -58.32%-104.15B | -69.83%-126.09B | 56.79%-344.03B | -263.29%-128.23B | -30.36%-75.77B | 89.78%-65.79B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net issuance payments of debt | -1,107.80%-26.24B | 126.80%113.66B | 106.80%4.55B | -244.05%-83.01B | 270.38%189.52B | 100.86%2.6B | -293.53%-424.1B | -137.76%-66.94B | 191.86%57.63B | -211.31%-111.23B |
| Net common stock issuance | 16.67%-10M | 2.00%-49M | -37.50%-11M | -57.14%-11M | -114.29%-15M | 57.14%-12M | -16.28%-50M | 11.11%-8M | 41.67%-7M | 41.67%-7M |
| Cash dividends paid | -16.68%-40.85B | -8.34%-75.86B | --0 | -16.68%-40.85B | --0 | -0.01%-35.01B | -20.02%-70.02B | --0 | -0.01%-35.01B | --0 |
| Net other financing activities | 120.42%193M | -93.54%-27.93B | -601.97%-23.47B | 102.75%179M | -309.70%-3.7B | 93.42%-945M | -13.68%-14.43B | 793.62%4.68B | -86.77%-6.51B | 140.86%1.76B |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -24.01%-77.27B | 86.25%-83.49B | 49.51%-45.64B | -1,532.65%-140.91B | 229.43%165.37B | 83.61%-62.31B | -1,130.41%-607.01B | -160.76%-90.41B | 92.77%-8.63B | -268.91%-127.77B |
| Net cash flow | ||||||||||
| Beginning cash position | 36.62%1.12T | -32.04%819.5B | 26.61%1.04T | 37.51%1.16T | -4.00%909.95B | -32.04%819.5B | -24.31%1.21T | -7.83%820.1B | -13.14%847.19B | -41.68%947.88B |
| Current changes in cash | -267.44%-64B | 147.54%204.56B | 309.84%24.39B | -521.05%-84.4B | 311.97%226.35B | 111.51%38.22B | 11.21%-430.3B | -104.43%-11.62B | 117.42%20.04B | 83.74%-106.79B |
| Effect of exchange rate changes | 20.07%62.71B | 117.54%95.57B | 416.41%56.92B | 29.38%-42.28B | 52.36%28.7B | -29.37%52.23B | -54.62%43.93B | -79.60%11.02B | -302.33%-59.88B | 185.71%18.83B |
| End cash Position | 22.90%1.12T | 36.62%1.12T | 36.62%1.12T | 26.61%1.04T | 37.51%1.16T | -4.00%909.95B | -32.04%819.5B | -32.04%819.5B | -7.83%820.1B | -13.14%847.19B |
| Free cash flow | -67.21%30.55B | 45.63%219.7B | -26.25%63.87B | 273.17%41.44B | 284.80%21.21B | 95.59%93.17B | 434.15%150.86B | 34.54%86.6B | 186.53%11.11B | 103.61%5.51B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |